Thus, we silenced PASK in HepG2 cells and found that inhibition of PASK could reverse the events caused NAFLD/NASH, which was simultaneously evaluated along with nuciferine and vitamin E. The gene discussed is PASK; the disease is metabolic dysfunction-associated steatotic liver disease.